Neutral impactStocks
Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or S
The Economic Times 1 hr ago·30 Jul 2026, 4:03 am
Stocks The Economic Times
The second day of bidding for the Manipal Health Enterprises IPO saw the GMP, or grey market premium, holding steady at 2%. This means the listing price is expected to be around the issue price. The issue has attracted subscriptions of 15% so far, indicating a lukewarm response from investors.
This lackluster demand suggests that retail investors are cautious about the valuation. The healthcare sector is generally considered defensive, but the high price tag may be a deterrent. The IPO's success will largely depend on the company's financial performance and the broader market sentiment.
Investors should watch for the final subscription numbers and the company's financial health. A strong showing in the final days could boost the stock's listing gains. Conversely, a weak response might lead to a muted listing. It is important to evaluate the company's fundamentals before taking a decision.
Key takeaways
- Category: Stocks.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. Use the price and stock snapshot to gauge how the market is responding.
